For the Inventor, By the Inventor

Enter inventor name

Arlington, MA, United States of America

Ngan Nguyen

This inventor holds 11 USPTO granted patents, plus 5 CIPO patents and 5 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ngan Nguyen. Retrieved from https://idiyas.com/inventor/ngan-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

Somerville, MA (US) (2015)
Arlington, MA (US) (2017 - 2022)

Company Filing History:

11 out of 3,025

Merck Patent Gmbh

Years Active: 2015-2022

Loading Chart...

Loading Chart...

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11365199 - Pyrazole compounds as modulators of FSHR and uses thereof (2022-06-21),

2. 10413562 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2019-09-17),

3. 10138233 - Imidazole compounds as modulators of FSHR and uses thereof (2018-11-27),

4. 10081637 - Pyrazole compounds as modulators of FSHR and uses thereof (2018-09-25),

5. 10030013 - Heteroaryl compounds as IRAK inhibitors and uses thereof (2018-07-24),

6. 10016448 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2018-07-10),

7. 10005784 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof (2018-06-26),

8. 9790221 - Heteroaryl compounds as IRAK inhibitors and uses thereof (2017-10-17),

9. 9738648 - Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof (2017-08-22),

10. 9580449 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2017-02-28),

11. 9073947 - Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity (2015-07-07),

Title: Ngan Nguyen: Innovator in Pharmaceutical Compounds

Introduction

Ngan Nguyen is a prominent inventor based in Arlington, MA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Nguyen has made remarkable strides in developing innovative compounds that have the potential to impact various medical conditions.

Latest Patents

Nguyen's latest patents include groundbreaking work on pyrazole compounds, which serve as positive allosteric modulators of the follicle-stimulating hormone receptor (FSHR). This invention relates to the development of pyrazole compounds and their pharmaceutically acceptable compositions. Additionally, he has worked on compositions and methods for producing pyrimidine and pyridine compounds that exhibit Bruton's tyrosine kinase (BTK) inhibitory activity. These compounds are aimed at treating hyperproliferative diseases, including cancer, lupus, allergic disorders, Sjogren's disease, and rheumatoid arthritis.

Career Highlights

Ngan Nguyen is currently associated with Merck Patent GmbH, where he continues to push the boundaries of pharmaceutical research and development. His work has not only contributed to the scientific community but has also paved the way for new treatment options for patients suffering from various diseases.

Collaborations

Nguyen collaborates with talented individuals in his field, including Reinaldo Jones and Lesley Liu-Bujalski, who bring diverse expertise to their projects. Their teamwork enhances the innovative potential of their research endeavors.

Conclusion

Ngan Nguyen's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a key inventor in the industry. His work continues to inspire advancements in medical treatments and compounds.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…